Returns At Omda (OB:OMDA) Are On The Way Up
Jul 24
Norwegian (OSEAX) Healthcare Sector Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies25
- 7D-1.2%
- 3M0.3%
- 1Y-32.0%
- YTD-28.9%
Over the last 7 days, the Healthcare industry has dropped 1.2%, driven by Nykode Therapeutics declining 3.9%. Meanwhile, Gentian Diagnostics actually outperformed within the industry, gaining 7.5% in the last week. Overall the industry is down 32% in 12 months. Looking forward, earnings are forecast to grow by 24% annually.
Sector Valuation and Performance
Has the Norwegian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | NOK 21.7b | NOK 4.0b | -NOK 984,772,998.08 | 16.6x | -22.1x | 5.4x |
| Sun, 23 Jun 2024 | NOK 22.2b | NOK 4.1b | -NOK 944,845,448.45 | 15.6x | -23.5x | 5.4x |
| Tue, 21 May 2024 | NOK 22.1b | NOK 4.2b | -NOK 1,169,738,370.72 | 17.3x | -18.9x | 5.2x |
| Thu, 18 Apr 2024 | NOK 21.3b | NOK 4.2b | -NOK 1,124,001,078.73 | 28x | -19x | 5.1x |
| Sat, 16 Mar 2024 | NOK 21.6b | NOK 4.2b | -NOK 1,083,284,989.41 | 27.7x | -19.9x | 5.1x |
| Mon, 12 Feb 2024 | NOK 28.6b | NOK 4.1b | -NOK 1,297,890,108.42 | 24x | -22x | 6.9x |
| Wed, 10 Jan 2024 | NOK 30.8b | NOK 4.1b | -NOK 1,582,520,914.00 | 23.5x | -19.4x | 7.5x |
| Fri, 08 Dec 2023 | NOK 27.7b | NOK 4.1b | -NOK 1,594,738,436.00 | 21.1x | -17.4x | 6.8x |
| Sun, 05 Nov 2023 | NOK 26.4b | NOK 3.5b | -NOK 1,853,221,288.00 | 32.6x | -14.2x | 7.6x |
| Tue, 03 Oct 2023 | NOK 28.1b | NOK 3.5b | -NOK 1,799,208,286.00 | 33.2x | -15.6x | 7.9x |
| Thu, 31 Aug 2023 | NOK 28.2b | NOK 3.6b | -NOK 1,796,969,931.00 | 32.1x | -15.7x | 7.9x |
| Sat, 29 Jul 2023 | NOK 29.7b | NOK 3.4b | -NOK 1,818,947,771.00 | 29.9x | -16.3x | 8.8x |
| Mon, 26 Jun 2023 | NOK 28.9b | NOK 3.4b | -NOK 1,803,192,839.00 | 42.2x | -16x | 8.5x |
| Wed, 24 May 2023 | NOK 30.6b | NOK 3.4b | -NOK 1,823,924,148.00 | 41.4x | -16.8x | 9x |
| Fri, 21 Apr 2023 | NOK 31.3b | NOK 3.1b | -NOK 1,790,861,945.00 | 32x | -17.5x | 10x |
| Sun, 19 Mar 2023 | NOK 28.0b | NOK 3.1b | -NOK 1,881,262,236.00 | 29.3x | -14.9x | 9x |
| Tue, 14 Feb 2023 | NOK 33.4b | NOK 3.6b | -NOK 1,855,499,381.00 | 35.4x | -18x | 9.3x |
| Thu, 12 Jan 2023 | NOK 33.2b | NOK 3.6b | -NOK 1,837,929,544.00 | 34.6x | -18x | 9.2x |
| Sat, 10 Dec 2022 | NOK 35.1b | NOK 3.6b | -NOK 1,834,084,335.00 | 37.4x | -19.1x | 9.8x |
| Mon, 07 Nov 2022 | NOK 32.5b | NOK 3.5b | -NOK 1,754,923,360.00 | 39.3x | -18.5x | 9.3x |
| Wed, 05 Oct 2022 | NOK 31.5b | NOK 3.4b | -NOK 1,773,858,460.00 | 57.5x | -17.8x | 9.1x |
| Fri, 02 Sep 2022 | NOK 35.4b | NOK 3.4b | -NOK 1,763,568,221.00 | 58.2x | -20.1x | 10.4x |
| Sun, 31 Jul 2022 | NOK 38.2b | NOK 3.3b | -NOK 1,739,139,871.00 | 87.3x | -21.9x | 11.7x |
| Tue, 28 Jun 2022 | NOK 37.0b | NOK 3.3b | -NOK 1,701,722,626.00 | 53.1x | -21.7x | 11.2x |
| Thu, 26 May 2022 | NOK 36.8b | NOK 3.6b | -NOK 1,322,668,227.00 | 49.6x | -27.8x | 10.2x |
| Sat, 23 Apr 2022 | NOK 42.8b | NOK 3.5b | -NOK 1,203,579,388.00 | 43.3x | -35.6x | 12.4x |
| Mon, 21 Mar 2022 | NOK 43.3b | NOK 5.1b | NOK 176.3m | 38.6x | 245.4x | 8.5x |
| Wed, 16 Feb 2022 | NOK 47.2b | NOK 5.0b | NOK 328.0m | 60.9x | 144x | 9.5x |
| Fri, 14 Jan 2022 | NOK 59.4b | NOK 4.4b | -NOK 141,418,985.00 | 60.7x | -420.2x | 13.5x |
| Sun, 12 Dec 2021 | NOK 61.1b | NOK 4.5b | -NOK 85,118,601.00 | 66.8x | -718.1x | 13.7x |
| Tue, 09 Nov 2021 | NOK 61.0b | NOK 4.7b | NOK 362.0m | 48x | 168.5x | 13x |
| Thu, 07 Oct 2021 | NOK 61.0b | NOK 4.7b | NOK 386.4m | 64.8x | 157.9x | 13.1x |
| Sat, 04 Sep 2021 | NOK 64.8b | NOK 4.6b | NOK 425.6m | 65.4x | 152.3x | 14x |
| Mon, 02 Aug 2021 | NOK 58.9b | NOK 4.6b | NOK 425.6m | 68.1x | 138.5x | 12.7x |
Price to Earnings Ratio
138.5x
Current Industry PE
- Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 9.3x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 4.7% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare sector?
| NO Market | -1.27% | |
| Healthcare | -1.16% | |
| Medical Equipment | 1.06% | |
| Healthtech | 0.33% | |
| Life Sciences | 0% | |
| Pharma | -1.92% | |
| Healthcare Services | -2.34% | |
| Biotech | -2.76% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 53.7%, which is higher than its past year's earnings decline of 8.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 77% over the next 5 years.
- However this is lower than its past earnings growth rate of 655% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 4.3% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GENT Gentian Diagnostics | NOK 57.00 | 7.5% +NOK 61.7m | 21.5% | PS5.9x | |
| OMDA Omda | NOK 39.80 | 7.6% +NOK 57.2m | -7.4% | PE9.2x | |
| ULTI Ultimovacs | NOK 7.90 | 3.9% +NOK 10.3m | -89.8% | PB1x | |
| CODE CodeLab Capital | NOK 0.35 | 16.1% +NOK 9.8m | -14.1% | PE1.8x | |
| MEDI Medistim | NOK 170.00 | 0.3% +NOK 9.2m | -35.8% | PE30.4x |
